Literature DB >> 13297725

Acceptance of tumor homografts by mice injected with antiserum. I. Activity of serum fractions.

N KALISS, A A KANDUTSCH.   

Abstract

Entities:  

Keywords:  IMMUNE SERUMS/effects; NEOPLASMS/transplantation

Mesh:

Substances:

Year:  1956        PMID: 13297725     DOI: 10.3181/00379727-91-22185

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  7 in total

1.  Specific immunological tolerance.

Authors:  M F WOODRUFF
Journal:  Klin Wochenschr       Date:  1958-03-15

2.  Serological responses of mice during active enhancement of tumour allografts.

Authors:  P Mildenhall; D S Nelson
Journal:  Br J Exp Pathol       Date:  1968-04

Review 3.  Active mechanisms of immunological tolerance.

Authors:  M Hasek; T Hraba
Journal:  Surv Immunol Res       Date:  1984

4.  Immunologic enhancement of allogeneic tumor growth with soluble histocompatibility-2 antigens.

Authors:  L W Law; E Appella; P W Wright; S Strober
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

5.  Studies on a substance that promotes tumor homograft survival (the enhancing substance); its distribution and some properties.

Authors:  A A KANDUTSCH; U REINERT-WENCK
Journal:  J Exp Med       Date:  1957-02-01       Impact factor: 14.307

6.  DEPRESSION BY ANTIBODY OF THE IMMUNE RESPONSE TO HOMOGRAFTS AND ITS ROLE IN IMMUNOLOGICAL ENHANCEMENT.

Authors:  G D Snell; H J Winn; J H Stimpfling; S J Parker
Journal:  J Exp Med       Date:  1960-08-01       Impact factor: 14.307

Review 7.  Engineering of Fc Multimers as a Protein Therapy for Autoimmune Disease.

Authors:  Elizabeth A Fitzpatrick; Jin Wang; S E Strome
Journal:  Front Immunol       Date:  2020-03-25       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.